Background Renal transplantation is the standard of care for patients with end-stage renal
disease. Although maintenance immunosuppression with calcineurin inhibitors yields …

Background Long-term administration of cyclosporin carries a risk of renal toxicity, and
immunosuppressants are associated with an increased rate of malignant disorders. We …

Background Use of cell-based medicinal products (CBMPs) represents a state-of-the-art
approach for reducing general immunosuppression in organ transplantation. We tested multiple …

The involvement of immunologic and nonimmunologic events in long-term kidney allograft
failure is difficult to assess. The development of HLA antibodies after transplantation is the …

Notwithstanding the ongoing coronavirus disease-2019 (Covid-19) pandemic, information
on its clinical presentation and prognosis in recipients of a kidney transplant remain scanty. …

There are no studies which have compared the risk of severe COVID‐19 and related mortality
between transplant recipients and nontransplant patients. We enrolled two groups of …

Delayed graft function of more than six days strongly decreases long-term survival of
transplanted kidneys. Background We reviewed 843 first cadaver kidney transplants carried out …

Background: Kidney transplant recipients receiving immunosuppressive drugs have impaired
immune responses to messenger RNA (mRNA) COVID-19 vaccines (1). Consequently, …

1. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19
vaccine. N Engl J Med. 2020; 383: 2603-2615. 2. Baden LR, El Sahly HM, Essink B, et al. …

Background Treatment of acute antibody-mediated rejection (AMR) is based on a combination
of plasma exchange (PE), IVIg, corticosteroids (CS), and rituximab, but the place of …